Cerus reported $50.81M in Sales Revenues for its fiscal quarter ending in December of 2024.





Sales Change Date
Cerus USD 50.81M 4.79M Dec/2024
GRIFOLS EUR 1.87B 170M Jun/2026
Haemonetics USD 339M 7M Jun/2026
Neogen USD 225.3M 14.1M Mar/2026
OraSure Technologies USD 26.76M 322K Dec/2025
Plus Therapeutics USD 1.03M 339K Mar/2026
Quidel USD 630.9M 10.9M Jun/2026
Rockwell Medical USD 25.83M 3.15M Jun/2024
STAAR Surgical USD 93.5M 0 Jun/2026
Terumo JPY 311.81B 11.49B Jun/2026
Utah Medical Products USD 8.72M 323K Mar/2026